Shizuko Aoki

613 total citations
9 papers, 511 citations indexed

About

Shizuko Aoki is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Shizuko Aoki has authored 9 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Shizuko Aoki's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Antifungal resistance and susceptibility (3 papers). Shizuko Aoki is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Antifungal resistance and susceptibility (3 papers). Shizuko Aoki collaborates with scholars based in United States, Malaysia and Thailand. Shizuko Aoki's co-authors include Hiroaki Mitsuya, James A. Kelley, Harry Ford, John S. Driscoll, Víctor E. Márquez, Samuel Broder, Jeri S. Roth, David G. Johns, Christopher K. H. Tseng and Françoise Méchinaud and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Journal of Medicinal Chemistry.

In The Last Decade

Shizuko Aoki

9 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shizuko Aoki United States 8 321 193 172 170 105 9 511
Nghe Nguyen‐Ba Canada 16 600 1.9× 358 1.9× 266 1.5× 256 1.5× 301 2.9× 25 977
Martin von Janta‐Lipinski Germany 15 280 0.9× 261 1.4× 184 1.1× 144 0.8× 122 1.2× 38 530
Iain S. Sim United States 11 204 0.6× 218 1.1× 219 1.3× 105 0.6× 147 1.4× 25 565
Junxing Shi United States 16 450 1.4× 257 1.3× 244 1.4× 155 0.9× 202 1.9× 39 864
Kenji Kitano Japan 11 425 1.3× 279 1.4× 122 0.7× 232 1.4× 264 2.5× 16 609
Ganesh D. Kini United States 15 149 0.5× 231 1.2× 135 0.8× 79 0.5× 277 2.6× 30 566
Christopher K. H. Tseng United States 13 407 1.3× 547 2.8× 230 1.3× 153 0.9× 252 2.4× 14 967
Stefania Lostia United States 9 461 1.4× 239 1.2× 270 1.6× 74 0.4× 110 1.0× 11 665
Danuta Madej Canada 8 153 0.5× 202 1.0× 157 0.9× 57 0.3× 157 1.5× 10 414
Jan Balzarini Belgium 8 207 0.6× 174 0.9× 115 0.7× 81 0.5× 138 1.3× 8 371

Countries citing papers authored by Shizuko Aoki

Since Specialization
Citations

This map shows the geographic impact of Shizuko Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shizuko Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shizuko Aoki more than expected).

Fields of papers citing papers by Shizuko Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shizuko Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shizuko Aoki. The network helps show where Shizuko Aoki may publish in the future.

Co-authorship network of co-authors of Shizuko Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Shizuko Aoki. A scholar is included among the top collaborators of Shizuko Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shizuko Aoki. Shizuko Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sugita, K, et al.. (1994). [Pharmacokinetic and clinical evaluations of fluconazole in pediatric patients].. PubMed. 47(3). 296–303. 4 indexed citations
2.
Shirasaka, Takuma, Eiji Kojima, Shizuko Aoki, et al.. (1991). Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides. Journal of Medicinal Chemistry. 34(5). 1606–1612. 29 indexed citations
3.
Barchi, Joseph J., Víctor E. Márquez, John S. Driscoll, et al.. (1991). Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. Journal of Medicinal Chemistry. 34(5). 1647–1655. 59 indexed citations
4.
Aoki, Shizuko, Robert Yarchoan, Rose V. Thomas, et al.. (1990). Quantitative Analysis of HIV-1 Proviral DNA in Peripheral Blood Mononuclear Cells from Patients with AIDS or ARC: Decrease of Proviral DNA Content Following Treatment with 2′,3′-Dideoxyinosine (ddI). AIDS Research and Human Retroviruses. 6(11). 1331–1339. 54 indexed citations
5.
Walsh, Thomas J., Shizuko Aoki, Françoise Méchinaud, et al.. (1990). Effects of Preventive, Early, and Late Antifungal Chemotherapy with Fluconazole in Different Granulocytopenic Models of Experimental Disseminated Candidiasis. The Journal of Infectious Diseases. 161(4). 755–760. 52 indexed citations
6.
Walsh, Thomas J., James Lee, Shizuko Aoki, et al.. (1990). Experimental Basis for Use of Fluconazole for Preventive or Early Treatment of Disseminated Candidiasis in Granulocytopenic Hosts. Clinical Infectious Diseases. 12(Supplement_3). S307–S317. 41 indexed citations
7.
Márquez, Víctor E., Christopher K. H. Tseng, Hiroaki Mitsuya, et al.. (1990). Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV. Journal of Medicinal Chemistry. 33(3). 978–985. 183 indexed citations
8.
Shirasaka, T, Harry Ford, James A. Kelley, et al.. (1990). Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro.. Proceedings of the National Academy of Sciences. 87(23). 9426–9430. 49 indexed citations
9.
Iyer, Radhakrishnan P., Lawrence R. Phillips, Dhiren R. Thakker, et al.. (1989). Synthesis of acyloxyalkyl acylphosphonates as potential prodrugs of the antiviral, trisodium phosphonoformate (foscarnet sodium). Tetrahedron Letters. 30(51). 7141–7144. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nghe Nguyen‐Ba Breakdown of academic impact, for papers by Martin von Janta‐Lipinski Breakdown of academic impact, for papers by Iain S. Sim Breakdown of academic impact, for papers by Junxing Shi Breakdown of academic impact, for papers by Kenji Kitano Breakdown of academic impact, for papers by Ganesh D. Kini Breakdown of academic impact, for papers by Christopher K. H. Tseng Breakdown of academic impact, for papers by Stefania Lostia Breakdown of academic impact, for papers by Danuta Madej Breakdown of academic impact, for papers by Jan Balzarini
Rankless by CCL
2026